Being global first reference in preservation and transport of organs and biological products with high impact revolutionary solutions.


Transplant Biomedicals is a European company based in Barcelona aimed at developing novel medical strategies to improve organ, tissue and cellular preservation to overall enhance patients´ wellness.

Our values are at the basis of all our organizations actions

  • Fight for our cause, the patient
  • Trust and commitment
  • Innovation, entrepreneurship, creativity and passion
  • Superior quality that meets needs and provides sustainable added value



Transplant Biomedicals is developing a new organ transport device available for hospital use. The device uses a revolutionary technology leading to superior preservation of the organs during transport from the donor hospital to the transplant center.

Our high quality and convenient product aims to become the global gold standard for transplant centers by reducing the risk of delayed graft function, improving graft survival and as such leading to better patient outcomes. In addition, our product has the potential to use part of the marginal organs that are currently discarded and thus reduce the waiting lists. [3D conceptual model]

“Our challenge is to achieve the perfection in our products to provide our users with solutions that guarantee excellence in the results of their invaluable work.”

Ignasi Heras – Chief Executive Officer


Ignasi Heras, MBA

Chief Executive Officer

Mr Heras is co-founder of Transplant Biomedicals. He has a long experience in the biomedical and biotechnology arena in business development and innovation, including public and private companies.

More information: LinkedIn

Carmen Peralta_Transplant_Biomedicals
Dra. Carmen Peralta

Chief Scientific Officer

Dr. Peralta is co-founder of Transplant Biomedicals. She is Senior Group Leader at IDIBAPS. Her expertise focuses in pharmacological and surgical strategies aimed at reducing hepatic ischemia/reperfusion injury associated with hepatic resections and liver transplantation.

More information: LinkedIn

Rafael Gran
Rafael Nualart

Chief Technology Officer

Mr. Rafel Nualart has over 20 years of experience in various sectors and markets being an expert on conception, design and development of products and services. From user insights, identifying what motivates consumers and at the same time evaluating new business opportunities in collaboration with potential technology partners.

More information: LinkedIn

Jordi Petit, MBA

Chief Financial Officer

Mr. Petit has worked during more than 25 years in different financial directive positions in both multinational and start-ups of recent creation in the life science sector.

More information: LinkedIn

Dr. Oriol Solà-Morales

Chief Medical & Market Access Officer

Dr. Solà-Morales has extensive knowledge of national and international healthcare ecosystems due to his experience in various management positions in research institutes, public agencies, hospitals and companies in the biomedical field.

More information: LinkedIn

Advisory Board

Prof. Juan Rodés

More information: Wikipedia

Dr. Enrique Castellón

More information: LinkedIn

Dr. Blanca Miranda
Silvina Ramella
Dra.Silvina Ramella

More information: LinkedIn

Raj Airey
Sr. Raj Airey

More information: LinkedIn



Transplant Biomedicals S.L.
Marie Curie, 8-14
Barcelona Advanced Industry Park
08042 Barcelona [Spain]
+34 935 27 27 20


January 2th 2017
Transplant Biomedicals closes €2.5M in Series A financing by Caixa Capital Risc and Kereon Partners. More information

November 11th 2016
Transplant Biomedicals raises €1.5M. More information.

If you want to invest in Transplant Biomedicals, please email us at: